Luciana Ramalho Pimentel-Silva
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Luciana Ramalho Pimentel-Silva has a total of 133 co-authors. Here are the top co-authors by number of shared publications:
- Fernando Cendes
Department of Neurology, School of Medical Sciences, University of Campinas (UNICAMP), Campinas, Brazil
13 shared publications - Brunno Machado de Campos
Neuroimaging Laboratory Universidade Estadual de Campinas Campinas São Paulo Brazil
4 shared publications Clarissa L. Yasuda
Department of Neurology University of Campinas Sao Paulo Brazil
4 shared publicationsClarissa Lin Yasuda
Laboratory of Neuroimaging, Department of Neurology University of Campinas Campinas Brazil
3 shared publications- Clarissa Lin Yasuda
Universidade Estadual de Campinas, Faculdade de Ciências Médicas, Departamento de Neurologia, Campinas SP, Brazil
3 shared publications Fabio Rogerio
Department of Anatomical Pathology, University of Campinas (UNICAMP), Campinas, São Paulo, Brazil
3 shared publications
Latest Publications
- Open Access
- 25 January 2026
- Published by Georg Thieme Verlag KG in Arquivos de Neuro-Psiquiatria
- Vol. 84 (01) , 001-002
Reply to: Temporal lobe epilepsy and its negative impact on quality of life: Could it improve through aerobic physical exercise?
Dear Editor, We would like to thank García Borja and Carranza for their interest in our study and welcome the opportunity to discuss key methodological aspects and findings. In their letter, García Borja and Carranza state that our study intervention—a 6-month aerobic physical exercise (APE) program—is a “non-pharmacological treatment aimed at improving quality of life (QoL).” We want to clarify that we aimed to investigate whether a supervised APE program could enhance the QoL of people with temporal lobe epilepsy (TLE) and influence patients' concerns regarding seizures, while effectively improving aerobic fitness. Although closely related, “treatment” and “intervention” are distinct concepts in this context. This distinction is important as it defines which conclusions can be drawn from our study, given its scope and goals. The study intervention was carried out in 2017; we appreciate García Borja and Carranza for pointing out this missing chronological detail. For context, we used the 2017 ILAE classification,[1] the standard in place until the recent 2025 updates.[2] Thus, the study's temporal context does not preclude valid interpretations of our findings. Although our sample size is modest, we respectfully disagree with the claim that our non-significant results are solely due to insufficient statistical power, “making the findings less specific and conclusive.” Our study design allowed modelling within- and between-group interactions, which increases statistical rigor and minimizes type-I errors compared to multiple subgroup testing.[3] [4] We demonstrated that physical capacity and overall QoL significantly improved in the intervention group only, despite no significant changes in the seizure worry domain. This indicates that the findings are related to the APE program and, therefore, specific to the intervention. Regarding the mention of “high p-values,” we assume the authors refer to the non-significant differences in clinical features. We maintain that a p-value should not be interpreted in terms of “strength” but rather against the established threshold of significance. To move beyond a p-value-only interpretation, we reported effect sizes, which showed moderate-to-large strength for significant outcomes, while non-significant differences had small effect sizes. These non-significant results across clinical characterizations likely indicate that the effects of potential confounders were negligible, reflecting our success in recruiting a representative sample. Therefore, we disagree that the influence of confounders cannot be appreciated, since the main clinical features that could influence outcomes were clearly described and statistically tested. Our choice of tools stems from the use of gold-standard, validated methods: the cardiopulmonary exercise test for aerobic fitness[5] and the Quality of Life in Epilepsy Inventory (QOLIE-31)[6] for QoL. These tools are robust and sensitive for use in the epilepsy population in the context of physical activity, as previously demonstrated by our group.[7] Regarding blinding, in this study design, assignment blinding is neither a requirement nor feasible, as the control group does not undergo a sham intervention. Furthermore, the QOLIE-31 is a self-reported inventory, which inherently minimizes rater bias. Finally, García Borja and Carranza raised valid safety concerns. While we agree that seizure control status should be taken into account, there is evidence of minimal or no influence of exercise in predisposing seizures in humans and animal models,[8] [9] as discussed in our report. Nonetheless, our study was an exploratory pilot study on supervised APE and QoL, not a clinical trial designed to assess seizure risk and the safety and efficacy of physical exercise. Consequently, we could offer only insights into the safety of supervised aerobic exercise with individualized intensity. In conclusion, we believe that our findings were appropriately interpreted within the context and boundaries of our research question. Our study indicates that supervised APE improved QoL without significant changes in seizure worry in a well-defined sample of people with chronic TLE. Supervised, systematic exercise could serve as a valuable tool in lessening the burden of TLE on wellbeing. Our findings warrant further investigation into other biopsychosocial aspects of epilepsy, and large-scale randomized trials remain necessary to determine the definitive safety and efficacy of exercise on seizure burden. Conceptualization: SOL, LRPS, FC; Data curation: SOL, NV, NC, MHN, CLY, LRPS, FC; Formal analysis: SOL, NV, NC, MHN, CLY, LRPS, FC; Investigation: SOL, NV, NC, MHN, CLY, LRPS, FC; Methodology: SOL, NV, NC, MHN, CLY, LRPS, FC; Project administration: SOL, LRPS, FC; Supervision: SOL, LRPS, FC; Validation: SOL, LRPS, FC; Visualization: SOL, LRPS, FC; Writing - original draft: SOL, LRPS, FC; Writing - review & editing: SOL, NV, NC, MHN, CLY, LRPS, FC. No new data were generated or analyzed in this study. Editor-in-Chief: Hélio A. G. Teive (https://orcid.org/0000-0003-2305-1073). Received: 19 December 2025 Accepted: 05 January 2026 Article published online: 12 March 2026 © 2026. The Author(s). This is an open access article published by Thieme under the terms of the Creative Commons Attribution 4.0 International License, permitting copying and reproduction so long as the original work is given appropriate credit (https://creativecommons.org/licenses/by/4.0/) Thieme Revinter Publicações Ltda. Rua Rego Freitas, 175, loja 1, República, São Paulo, SP, CEP 01220-010, Brazil
- 25 January 2026
- Published by Georg Thieme Verlag KG in Arquivos de Neuro-Psiquiatria
- Vol. 84 (01) , 001-002
Open AccessReply to: Temporal lobe epilepsy and its negative impact on quality of life: Could it improve through aerobic physical exercise?
Dear Editor, We would like to thank García Borja and Carranza for their interest in our study and welcome the opportunity to discuss key methodological aspects and findings. In their letter, García Borja and Carranza state that our study intervention—a 6-month aerobic physical exercise (APE) program—is a “non-pharmacological treatment aimed at improving quality of life (QoL).” We want to clarify that we aimed to investigate whether a supervised APE program could enhance the QoL of people with temporal lobe epilepsy (TLE) and influence patients' concerns regarding seizures, while effectively improving aerobic fitness. Although closely related, “treatment” and “intervention” are distinct concepts in this context. This distinction is important as it defines which conclusions can be drawn from our study, given its scope and goals. The study intervention was carried out in 2017; we appreciate García Borja and Carranza for pointing out this missing chronological detail. For context, we used the 2017 ILAE classification,[1] the standard in place until the recent 2025 updates.[2] Thus, the study's temporal context does not preclude valid interpretations of our findings. Although our sample size is modest, we respectfully disagree with the claim that our non-significant results are solely due to insufficient statistical power, “making the findings less specific and conclusive.” Our study design allowed modelling within- and between-group interactions, which increases statistical rigor and minimizes type-I errors compared to multiple subgroup testing.[3] [4] We demonstrated that physical capacity and overall QoL significantly improved in the intervention group only, despite no significant changes in the seizure worry domain. This indicates that the findings are related to the APE program and, therefore, specific to the intervention. Regarding the mention of “high p-values,” we assume the authors refer to the non-significant differences in clinical features. We maintain that a p-value should not be interpreted in terms of “strength” but rather against the established threshold of significance. To move beyond a p-value-only interpretation, we reported effect sizes, which showed moderate-to-large strength for significant outcomes, while non-significant differences had small effect sizes. These non-significant results across clinical characterizations likely indicate that the effects of potential confounders were negligible, reflecting our success in recruiting a representative sample. Therefore, we disagree that the influence of confounders cannot be appreciated, since the main clinical features that could influence outcomes were clearly described and statistically tested. Our choice of tools stems from the use of gold-standard, validated methods: the cardiopulmonary exercise test for aerobic fitness[5] and the Quality of Life in Epilepsy Inventory (QOLIE-31)[6] for QoL. These tools are robust and sensitive for use in the epilepsy population in the context of physical activity, as previously demonstrated by our group.[7] Regarding blinding, in this study design, assignment blinding is neither a requirement nor feasible, as the control group does not undergo a sham intervention. Furthermore, the QOLIE-31 is a self-reported inventory, which inherently minimizes rater bias. Finally, García Borja and Carranza raised valid safety concerns. While we agree that seizure control status should be taken into account, there is evidence of minimal or no influence of exercise in predisposing seizures in humans and animal models,[8] [9] as discussed in our report. Nonetheless, our study was an exploratory pilot study on supervised APE and QoL, not a clinical trial designed to assess seizure risk and the safety and efficacy of physical exercise. Consequently, we could offer only insights into the safety of supervised aerobic exercise with individualized intensity. In conclusion, we believe that our findings were appropriately interpreted within the context and boundaries of our research question. Our study indicates that supervised APE improved QoL without significant changes in seizure worry in a well-defined sample of people with chronic TLE. Supervised, systematic exercise could serve as a valuable tool in lessening the burden of TLE on wellbeing. Our findings warrant further investigation into other biopsychosocial aspects of epilepsy, and large-scale randomized trials remain necessary to determine the definitive safety and efficacy of exercise on seizure burden. Conceptualization: SOL, LRPS, FC; Data curation: SOL, NV, NC, MHN, CLY, LRPS, FC; Formal analysis: SOL, NV, NC, MHN, CLY, LRPS, FC; Investigation: SOL, NV, NC, MHN, CLY, LRPS, FC; Methodology: SOL, NV, NC, MHN, CLY, LRPS, FC; Project administration: SOL, LRPS, FC; Supervision: SOL, LRPS, FC; Validation: SOL, LRPS, FC; Visualization: SOL, LRPS, FC; Writing - original draft: SOL, LRPS, FC; Writing - review & editing: SOL, NV, NC, MHN, CLY, LRPS, FC. No new data were generated or analyzed in this study. Editor-in-Chief: Hélio A. G. Teive (https://orcid.org/0000-0003-2305-1073). Received: 19 December 2025 Accepted: 05 January 2026 Article published online: 12 March 2026 © 2026. The Author(s). This is an open access article published by Thieme under the terms of the Creative Commons Attribution 4.0 International License, permitting copying and reproduction so long as the original work is given appropriate credit (https://creativecommons.org/licenses/by/4.0/) Thieme Revinter Publicações Ltda. Rua Rego Freitas, 175, loja 1, República, São Paulo, SP, CEP 01220-010, Brazil
- Open Access
- 21 January 2026
- Published by Elsevier in Brain Research
- Vol. 1875, 150180
Dynamic structural and metabolic changes during the epileptogenesis in the pilocarpine model of temporal lobe epilepsy: A longitudinal MRI study
- 21 January 2026
- Published by Elsevier in Brain Research
- Vol. 1875, 150180
Open AccessDynamic structural and metabolic changes during the epileptogenesis in the pilocarpine model of temporal lobe epilepsy: A longitudinal MRI study
- Open Access
- 4 February 2025
- Published by Georg Thieme Verlag KG in Arquivos de Neuro-Psiquiatria
- Vol. 83 (02) , 001-005
Aerobic physical exercise improves quality of life in temporal lobe epilepsy
Background A prior study showed that people with temporal lobe epilepsy (TLE) with an active lifestyle present a better quality of life (QoL), but the influence of aerobic physical exercise (APE) in the QoL of these patients is still unclear. As pharmacoresistance is commonly associated with TLE, the possibility of seizures during the activities might prevent patients from benefiting from APE. Objective To analyze the influence of APE in the QoL of TLE patients and also focus on the seizure worry subitem of the QoL in epilepsy 31 (QoLIE-31) questionnaire. Methods We analyzed data from 25 individuals with TLE who participated in a 6-month APE program under the supervision of a board-certified physical trainer. TLE patients were divided into training (TLE-training) and control (TLE-control) groups. The TLE-training group underwent an APE program of 6 months, while the control group was oriented to keep their routine. We assessed all patients with the QoLIE-31 at baseline and after 6 months. We used a mixed-between-subjects ANOVA to assess the APE intervention compared with TLE-control pre- and postintervention on the QoL. Results We found a significant interaction between intervention groups and APE-time (p = 0.0005), showing that only patients in the TLE-training group presented higher QoL after the intervention (p = 0.001). We found no significant differences between groups for seizure worry (p = 0.50). Conclusion There was improvement in QoL due to APE, with no increase in seizure worry, which might be a feature of concern for both patients and healthcare practitioners. Further studies should focus on long-term interventions to evaluate the impact of APE in QoL.
- 4 February 2025
- Published by Georg Thieme Verlag KG in Arquivos de Neuro-Psiquiatria
- Vol. 83 (02) , 001-005
Open AccessAerobic physical exercise improves quality of life in temporal lobe epilepsy
Background A prior study showed that people with temporal lobe epilepsy (TLE) with an active lifestyle present a better quality of life (QoL), but the influence of aerobic physical exercise (APE) in the QoL of these patients is still unclear. As pharmacoresistance is commonly associated with TLE, the possibility of seizures during the activities might prevent patients from benefiting from APE. Objective To analyze the influence of APE in the QoL of TLE patients and also focus on the seizure worry subitem of the QoL in epilepsy 31 (QoLIE-31) questionnaire. Methods We analyzed data from 25 individuals with TLE who participated in a 6-month APE program under the supervision of a board-certified physical trainer. TLE patients were divided into training (TLE-training) and control (TLE-control) groups. The TLE-training group underwent an APE program of 6 months, while the control group was oriented to keep their routine. We assessed all patients with the QoLIE-31 at baseline and after 6 months. We used a mixed-between-subjects ANOVA to assess the APE intervention compared with TLE-control pre- and postintervention on the QoL. Results We found a significant interaction between intervention groups and APE-time (p = 0.0005), showing that only patients in the TLE-training group presented higher QoL after the intervention (p = 0.001). We found no significant differences between groups for seizure worry (p = 0.50). Conclusion There was improvement in QoL due to APE, with no increase in seizure worry, which might be a feature of concern for both patients and healthcare practitioners. Further studies should focus on long-term interventions to evaluate the impact of APE in QoL.
- 2 January 2025
- Published by Springer Nature in GeroScience
- Vol. 47 (3) , 5267-5286
Resistance training protects the hippocampus and precuneus against atrophy and benefits white matter integrity in older adults with mild cognitive impairment
Mild cognitive impairment (MCI) refers to cognitive alterations with preservation of functionality. Individuals with this diagnosis have a higher risk of developing dementia. Non-pharmacological interventions, such as physical exercise, are beneficial for the cognition of this population. However, the impact of resistance training (RT) on the brain anatomy of older adults with MCI has not yet been clarified. This study aimed to investigate the effects of RT on cognition and brain anatomy in MCI. Forty-four older adults with MCI, 22 in the training group and 22 in the control group, were evaluated in neuropsychological tests and magnetic resonance imaging at the beginning and end of the study, which lasted 24 weeks. We used repeated measures ANOVA. The training group showed better performance in verbal episodic memory after intervention. The control group showed a decrease in gray matter volume in the hippocampus and precuneus, while the training group showed no reduction in the right hippocampus and precuneus. However, it showed a decrease in the volume of these regions on the left side and in the left superior frontal gyrus. In the analysis of white matter integrity, fractional anisotropy increased in the training group and decreased in the control group. Axial diffusivity decreased in the training group, while radial diffusivity increased in the control group, and mean diffusivity varied according to the tract evaluated. RT improves memory performance, positively influences white matter integrity parameters, and plays a protective role against atrophy of the hippocampus and precuneus in MCI.
- 2 January 2025
- Published by Springer Nature in GeroScience
- Vol. 47 (3) , 5267-5286
Resistance training protects the hippocampus and precuneus against atrophy and benefits white matter integrity in older adults with mild cognitive impairment
Mild cognitive impairment (MCI) refers to cognitive alterations with preservation of functionality. Individuals with this diagnosis have a higher risk of developing dementia. Non-pharmacological interventions, such as physical exercise, are beneficial for the cognition of this population. However, the impact of resistance training (RT) on the brain anatomy of older adults with MCI has not yet been clarified. This study aimed to investigate the effects of RT on cognition and brain anatomy in MCI. Forty-four older adults with MCI, 22 in the training group and 22 in the control group, were evaluated in neuropsychological tests and magnetic resonance imaging at the beginning and end of the study, which lasted 24 weeks. We used repeated measures ANOVA. The training group showed better performance in verbal episodic memory after intervention. The control group showed a decrease in gray matter volume in the hippocampus and precuneus, while the training group showed no reduction in the right hippocampus and precuneus. However, it showed a decrease in the volume of these regions on the left side and in the left superior frontal gyrus. In the analysis of white matter integrity, fractional anisotropy increased in the training group and decreased in the control group. Axial diffusivity decreased in the training group, while radial diffusivity increased in the control group, and mean diffusivity varied according to the tract evaluated. RT improves memory performance, positively influences white matter integrity parameters, and plays a protective role against atrophy of the hippocampus and precuneus in MCI.
- Open Access
- 31 July 2023
- Published by Wiley in Epilepsia Open
- Vol. 8 (3) , 1111-1122
Exploring the impact of hippocampal sclerosis on white matter tracts and memory in individuals with mesial temporal lobe epilepsy
Objective: To investigate how the presence/side of hippocampal sclerosis (HS) are related to the white matter structure of cingulum bundle (CB), arcuate fasciculus (AF), and inferior longitudinal fasciculus (ILF) in mesial temporal lobe epilepsy (MTLE).Methods: We acquired diffusion‐weighted magnetic resonance imaging (MRI) from 86 healthy and 71 individuals with MTLE (22 righ‐HS; right‐HS, 34 left‐HS; left‐HS, and 15 nonlesional MTLE). We utilized two‐tensor tractography and fiber clustering to compare fractional anisotropy (FA) of each side/tract between groups. Additionally, we examined the association between FA and nonverbal (WMS‐R) and verbal (WMS‐R, RAVLT codification) memory performance for MTLE individuals.Results: White matter abnormalities depended on the side and presence of HS. The left‐HS demonstrated widespread abnormalities for all tracts, the right‐HS showed lower FA for ipsilateral tracts and the nonlesional MTLE group did not differ from healthy individuals. Results indicate no differences in verbal/nonverbal memory performance between the groups, but trend‐level associations between higher FA of visual memory and the left CB (r = 0.286, P = 0.018), verbal memory (RAVLT) and ‐left CB (r = 0.335, P = 0.005), ‐right CB (r = 0.286, P = 0.016), and ‐left AF (r = 0.287, P = 0.017).Significance: Our results highlight that the presence and side of HS are crucial to understand the pathophysiology of MTLE. Specifically, left‐sided HS seems to be related to widespread bilateral white matter abnormalities. Future longitudinal studies should focus on developing diagnostic and treatment strategies dependent on HS's presence/side.
- 31 July 2023
- Published by Wiley in Epilepsia Open
- Vol. 8 (3) , 1111-1122
Open AccessExploring the impact of hippocampal sclerosis on white matter tracts and memory in individuals with mesial temporal lobe epilepsy
Objective: To investigate how the presence/side of hippocampal sclerosis (HS) are related to the white matter structure of cingulum bundle (CB), arcuate fasciculus (AF), and inferior longitudinal fasciculus (ILF) in mesial temporal lobe epilepsy (MTLE).Methods: We acquired diffusion‐weighted magnetic resonance imaging (MRI) from 86 healthy and 71 individuals with MTLE (22 righ‐HS; right‐HS, 34 left‐HS; left‐HS, and 15 nonlesional MTLE). We utilized two‐tensor tractography and fiber clustering to compare fractional anisotropy (FA) of each side/tract between groups. Additionally, we examined the association between FA and nonverbal (WMS‐R) and verbal (WMS‐R, RAVLT codification) memory performance for MTLE individuals.Results: White matter abnormalities depended on the side and presence of HS. The left‐HS demonstrated widespread abnormalities for all tracts, the right‐HS showed lower FA for ipsilateral tracts and the nonlesional MTLE group did not differ from healthy individuals. Results indicate no differences in verbal/nonverbal memory performance between the groups, but trend‐level associations between higher FA of visual memory and the left CB (r = 0.286, P = 0.018), verbal memory (RAVLT) and ‐left CB (r = 0.335, P = 0.005), ‐right CB (r = 0.286, P = 0.016), and ‐left AF (r = 0.287, P = 0.017).Significance: Our results highlight that the presence and side of HS are crucial to understand the pathophysiology of MTLE. Specifically, left‐sided HS seems to be related to widespread bilateral white matter abnormalities. Future longitudinal studies should focus on developing diagnostic and treatment strategies dependent on HS's presence/side.
- 15 June 2023
- Published by Springer Nature in Oral Radiology
- Vol. 39 (4) , 759-765
Magnetic resonance imaging evaluation of the disc morphology of temporomandibular joint in patients with severe hemophilia
Objectives This study aimed to assess the morphological differences in the articular disc (AD) between hemophilic patients and healthy individuals of the control group for further association with signs and symptoms. Methods Fourteen severe hemophilic patients had their AD evaluated by magnetic resonance imaging (MRI). The morphological findings were compared to those of a control group consisting of 14 healthy individuals. MRI was used to evaluate all the components of the temporomandibular (TMJ), including the AD, resulting in sequential T1-weighted parasagittal images. All the images were acquired with teeth in maximum intercuspation position. Results Morphological alterations showed significant statistical differences (P-value = 0.0068), whereas no statistical differences were found in the other variables, including TMJ pain, headache, bruxism and mouth opening limitation. In the group of non-hemophilic individuals, only two (14.29%) presented AD with non-biconcave features, whereas in the group of hemophilic patients, nine (64.29%) presented AD with a morphology other than biconcave. Conclusions In patients with severe hemophilia, there seems to be a pattern of morphological alterations in the articular disc over time. The standard biconcave morphology of AD tends to change into other ones, particularly biplanar, hemiconvex and folded.
- 15 June 2023
- Published by Springer Nature in Oral Radiology
- Vol. 39 (4) , 759-765
Magnetic resonance imaging evaluation of the disc morphology of temporomandibular joint in patients with severe hemophilia
Objectives This study aimed to assess the morphological differences in the articular disc (AD) between hemophilic patients and healthy individuals of the control group for further association with signs and symptoms. Methods Fourteen severe hemophilic patients had their AD evaluated by magnetic resonance imaging (MRI). The morphological findings were compared to those of a control group consisting of 14 healthy individuals. MRI was used to evaluate all the components of the temporomandibular (TMJ), including the AD, resulting in sequential T1-weighted parasagittal images. All the images were acquired with teeth in maximum intercuspation position. Results Morphological alterations showed significant statistical differences (P-value = 0.0068), whereas no statistical differences were found in the other variables, including TMJ pain, headache, bruxism and mouth opening limitation. In the group of non-hemophilic individuals, only two (14.29%) presented AD with non-biconcave features, whereas in the group of hemophilic patients, nine (64.29%) presented AD with a morphology other than biconcave. Conclusions In patients with severe hemophilia, there seems to be a pattern of morphological alterations in the articular disc over time. The standard biconcave morphology of AD tends to change into other ones, particularly biplanar, hemiconvex and folded.
- Open Access
- 19 May 2023
- Published by Wiley in Annals of Clinical and Translational Neurology
- Vol. 10 (7) , 1106-1118
Brain volumes and white matter diffusion across the adult lifespan in temporal lobe epilepsy
Objective: Typical aging is associated with gradual cognitive decline and changes in brain structure. The observation that cognitive performance in mesial temporal lobe epilepsy (TLE) patients diverges from controls early in life with subsequent decline running in parallel would suggest an initial insult but does not support accelerated decline secondary to seizures. Whether TLE patients demonstrate similar trajectories of age‐related gray (GM) and white matter (WM) changes as compared to healthy controls remains uncertain.Methods: 3D T1‐weighted and diffusion tensor images were acquired at a single site in 170 TLE patients (aged 23–74 years) with MRI signs of unilateral hippocampal sclerosis (HS, 77 right) and 111 healthy controls (aged 26–80 years). Global brain (GM, WM, total brain, and cerebrospinal fluid) and regional volumes (ipsi‐ and contralateral hippocampi), and fractional anisotropy (FA) of 10 tracts (three portions of corpus callosum, inferior longitudinal, inferior fronto‐occipital and uncinate fasciculi, body of fornix, dorsal and parahippocampal‐cingulum, and corticospinal tract) were compared between groups as a function of age.Results: There were significant reductions of global brain and hippocampi volumes (greatest ipsilateral to HS), and FA of all 10 tracts in TLE versus controls. For TLE patients, regression lines run in parallel to those from controls for brain volumes and FA (for all tracts except the parahippocampal‐cingulum and corticospinal tract) versus age across the adult lifespan.Interpretation: These results imply a developmental hindrance occurring earlier in life (likely in childhood/neurodevelopmental stages) rather than accelerated atrophy/degeneration of most brain structures herein analyzed in patients with TLE.
- 19 May 2023
- Published by Wiley in Annals of Clinical and Translational Neurology
- Vol. 10 (7) , 1106-1118
Open AccessBrain volumes and white matter diffusion across the adult lifespan in temporal lobe epilepsy
Objective: Typical aging is associated with gradual cognitive decline and changes in brain structure. The observation that cognitive performance in mesial temporal lobe epilepsy (TLE) patients diverges from controls early in life with subsequent decline running in parallel would suggest an initial insult but does not support accelerated decline secondary to seizures. Whether TLE patients demonstrate similar trajectories of age‐related gray (GM) and white matter (WM) changes as compared to healthy controls remains uncertain.Methods: 3D T1‐weighted and diffusion tensor images were acquired at a single site in 170 TLE patients (aged 23–74 years) with MRI signs of unilateral hippocampal sclerosis (HS, 77 right) and 111 healthy controls (aged 26–80 years). Global brain (GM, WM, total brain, and cerebrospinal fluid) and regional volumes (ipsi‐ and contralateral hippocampi), and fractional anisotropy (FA) of 10 tracts (three portions of corpus callosum, inferior longitudinal, inferior fronto‐occipital and uncinate fasciculi, body of fornix, dorsal and parahippocampal‐cingulum, and corticospinal tract) were compared between groups as a function of age.Results: There were significant reductions of global brain and hippocampi volumes (greatest ipsilateral to HS), and FA of all 10 tracts in TLE versus controls. For TLE patients, regression lines run in parallel to those from controls for brain volumes and FA (for all tracts except the parahippocampal‐cingulum and corticospinal tract) versus age across the adult lifespan.Interpretation: These results imply a developmental hindrance occurring earlier in life (likely in childhood/neurodevelopmental stages) rather than accelerated atrophy/degeneration of most brain structures herein analyzed in patients with TLE.
Superficial and deep white matter diffusion abnormalities in focal epilepsies
Objective: This study was undertaken to evaluate superficial‐white matter (WM) and deep‐WM magnetic resonance imaging diffusion tensor imaging (DTI) metrics and identify distinctive patterns of microstructural abnormalities in focal epilepsies of diverse etiology, localization, and response to antiseizure medication (ASM).Methods: We examined DTI data for 113 healthy controls and 113 patients with focal epilepsies: 51 patients with temporal lobe epilepsy (TLE) and hippocampal sclerosis (HS) refractory to ASM, 27 with pharmacoresponsive TLE‐HS, 15 with temporal lobe focal cortical dysplasia (FCD), and 20 with frontal lobe FCD. To assess WM microstructure, we used a multicontrast multiatlas parcellation of DTI. We evaluated fractional anisotropy (FA), mean diffusivity (MD), radial diffusivity (RD), and axial diffusivity (AD), and assessed within‐group differences ipsilateral and contralateral to the epileptogenic lesion, as well as between‐group differences, in regions of interest (ROIs).Results: The TLE‐HS groups presented more widespread superficial‐ and deep‐WM diffusion abnormalities than both FCD groups. Concerning superficial WM, TLE‐HS groups showed multilobar ipsilateral and contralateral abnormalities, with less extensive distribution in pharmacoresponsive patients. Both the refractory TLE‐HS and pharmacoresponsive TLE‐HS groups also presented pronounced changes in ipsilateral frontotemporal ROIs (decreased FA and increased MD, RD, and AD). Conversely, FCD patients showed diffusion changes almost exclusively adjacent to epileptogenic areas.Significance: Our findings add further evidence of widespread abnormalities in WM diffusion metrics in patients with TLE‐HS compared to other focal epilepsies. Notably, superficial‐WM microstructural damage in patients with FCD is more restricted around the epileptogenic lesion, whereas TLE‐HS groups showed diffuse WM damage with ipsilateral frontotemporal predominance. These findings suggest the potential of superficial‐WM analysis for better understanding the biological mechanisms of focal epilepsies, and identifying dysfunctional networks and their relationship with the clinical–pathological phenotype. In addition, lobar superficial‐WM abnormalities may aid in the diagnosis of subtle FCDs.
Superficial and deep white matter diffusion abnormalities in focal epilepsies
Objective: This study was undertaken to evaluate superficial‐white matter (WM) and deep‐WM magnetic resonance imaging diffusion tensor imaging (DTI) metrics and identify distinctive patterns of microstructural abnormalities in focal epilepsies of diverse etiology, localization, and response to antiseizure medication (ASM).Methods: We examined DTI data for 113 healthy controls and 113 patients with focal epilepsies: 51 patients with temporal lobe epilepsy (TLE) and hippocampal sclerosis (HS) refractory to ASM, 27 with pharmacoresponsive TLE‐HS, 15 with temporal lobe focal cortical dysplasia (FCD), and 20 with frontal lobe FCD. To assess WM microstructure, we used a multicontrast multiatlas parcellation of DTI. We evaluated fractional anisotropy (FA), mean diffusivity (MD), radial diffusivity (RD), and axial diffusivity (AD), and assessed within‐group differences ipsilateral and contralateral to the epileptogenic lesion, as well as between‐group differences, in regions of interest (ROIs).Results: The TLE‐HS groups presented more widespread superficial‐ and deep‐WM diffusion abnormalities than both FCD groups. Concerning superficial WM, TLE‐HS groups showed multilobar ipsilateral and contralateral abnormalities, with less extensive distribution in pharmacoresponsive patients. Both the refractory TLE‐HS and pharmacoresponsive TLE‐HS groups also presented pronounced changes in ipsilateral frontotemporal ROIs (decreased FA and increased MD, RD, and AD). Conversely, FCD patients showed diffusion changes almost exclusively adjacent to epileptogenic areas.Significance: Our findings add further evidence of widespread abnormalities in WM diffusion metrics in patients with TLE‐HS compared to other focal epilepsies. Notably, superficial‐WM microstructural damage in patients with FCD is more restricted around the epileptogenic lesion, whereas TLE‐HS groups showed diffuse WM damage with ipsilateral frontotemporal predominance. These findings suggest the potential of superficial‐WM analysis for better understanding the biological mechanisms of focal epilepsies, and identifying dysfunctional networks and their relationship with the clinical–pathological phenotype. In addition, lobar superficial‐WM abnormalities may aid in the diagnosis of subtle FCDs.
Inflammatory and neurotrophic factor plasma levels are related to epilepsy independently of etiology
Objective: Inflammation plays an essential role in epilepsy. Studies indicate that cytokines and neurotrophic factors can act in neuroexcitability and epileptogenesis. We aimed to investigate the association between plasma inflammatory and neurotrophic markers, seizure frequency, and chronic epilepsy subtypes.Methods: We studied 446 patients with epilepsy and 166 healthy controls. We classified patients according to etiology and seizure frequency. We measured plasma levels of interleukin‐1 (IL‐1), IL‐2, IL‐4, IL‐6, IL‐10, IL‐17, interferon‐γ (IFNγ), tumor necrosis factor α (TNFα), soluble TNF receptor 1 (sTNFr1), sTNFr2, brain‐derived neurotrophic factor (BDNF), neurotrophic factor 3 (NT3), NT4/5, ciliary neurotrophic factor (CNTF), nerve growth factor (NGF), and glial cell line‐derived neurotrophic factor (GDNF) by enzyme‐linked immunosorbent assay or cytometric bead array.Results: The plasma levels of BDNF, NT3, NGF, and sTNFr2 were higher, whereas IL‐2, IL‐4, IL‐6, IL‐10, IL‐17, IFNγ, TNFα, CNTF, and sTNFr1 were lower in patients than controls. IL1, GDNF, and NT4/5 were similar between groups. These markers did not correlate with age, sex, and epilepsy duration. The molecule sTNFr2 was the best marker to discriminate patients from controls (area under the curve = .857), also differing between patients with frequent and infrequent seizures.Significance: This large cohort confirmed that patients with epilepsy have abnormal levels of plasma inflammatory and neurotrophic markers independent of the underlying etiology. Plasma level of sTNFr2 was related to seizure frequency and discriminated people with or without epilepsy with good accuracy, making it a potential biomarker for epilepsy and seizure burden.
Inflammatory and neurotrophic factor plasma levels are related to epilepsy independently of etiology
Objective: Inflammation plays an essential role in epilepsy. Studies indicate that cytokines and neurotrophic factors can act in neuroexcitability and epileptogenesis. We aimed to investigate the association between plasma inflammatory and neurotrophic markers, seizure frequency, and chronic epilepsy subtypes.Methods: We studied 446 patients with epilepsy and 166 healthy controls. We classified patients according to etiology and seizure frequency. We measured plasma levels of interleukin‐1 (IL‐1), IL‐2, IL‐4, IL‐6, IL‐10, IL‐17, interferon‐γ (IFNγ), tumor necrosis factor α (TNFα), soluble TNF receptor 1 (sTNFr1), sTNFr2, brain‐derived neurotrophic factor (BDNF), neurotrophic factor 3 (NT3), NT4/5, ciliary neurotrophic factor (CNTF), nerve growth factor (NGF), and glial cell line‐derived neurotrophic factor (GDNF) by enzyme‐linked immunosorbent assay or cytometric bead array.Results: The plasma levels of BDNF, NT3, NGF, and sTNFr2 were higher, whereas IL‐2, IL‐4, IL‐6, IL‐10, IL‐17, IFNγ, TNFα, CNTF, and sTNFr1 were lower in patients than controls. IL1, GDNF, and NT4/5 were similar between groups. These markers did not correlate with age, sex, and epilepsy duration. The molecule sTNFr2 was the best marker to discriminate patients from controls (area under the curve = .857), also differing between patients with frequent and infrequent seizures.Significance: This large cohort confirmed that patients with epilepsy have abnormal levels of plasma inflammatory and neurotrophic markers independent of the underlying etiology. Plasma level of sTNFr2 was related to seizure frequency and discriminated people with or without epilepsy with good accuracy, making it a potential biomarker for epilepsy and seizure burden.
- 19 July 2021
- Published by Springer Nature in Neuroradiology
- Vol. 64 (1) , 141-150
Differences in structural and functional default mode network connectivity in amyloid positive mild cognitive impairment: a longitudinal study
Purpose Default mode network (DMN) has emerged as a potential biomarker of Alzheimer’s disease (AD); however, it is not clear whether it can differentiate amnestic mild cognitive impairment with altered amyloid (aMCI-Aβ +) who will evolve to AD. We evaluated if structural and functional connectivity (FC), hippocampal volumes (HV), and cerebrospinal fluid biomarkers (CSF—Aβ42, p-Tau, and t-Tau) can differentiate aMCI-Aβ + converters from non-converters. Methods Forty-eight individuals (18 normal controls and 30 aMCI subjects in the AD continuum — with altered Aβ42 in the CSF) were followed up for an average of 13 months. We used MultiAtlas, UF2C, and Freesurfer software to evaluate diffusion tensor imaging, FC, and HV, respectively, INNOTEST® kits to measure CSF proteins, and neuropsychological tests. Besides, we performed different MANOVAs with further univariate analyses to differentiate groups. Results During follow-up, 8/30 aMCI-Aβ + converted (26.6%) to AD dementia. There were no differences in multivariate analysis between groups in CSF biomarkers (p = 0.092) or at DMN functional connectivity (p = 0.814). aMCI-Aβ + converters had smaller right HV than controls (p = 0.013), and greater right cingulum parahippocampal bundle radial diffusivity than controls (p < 0.001) and non-converters (p = 0.036). Conclusion In this exploratory study, structural, but not functional, DMN connectivity alterations may differentiate aMCI-Aβ + subjects who converted to AD dementia.
- 19 July 2021
- Published by Springer Nature in Neuroradiology
- Vol. 64 (1) , 141-150
Differences in structural and functional default mode network connectivity in amyloid positive mild cognitive impairment: a longitudinal study
Purpose Default mode network (DMN) has emerged as a potential biomarker of Alzheimer’s disease (AD); however, it is not clear whether it can differentiate amnestic mild cognitive impairment with altered amyloid (aMCI-Aβ +) who will evolve to AD. We evaluated if structural and functional connectivity (FC), hippocampal volumes (HV), and cerebrospinal fluid biomarkers (CSF—Aβ42, p-Tau, and t-Tau) can differentiate aMCI-Aβ + converters from non-converters. Methods Forty-eight individuals (18 normal controls and 30 aMCI subjects in the AD continuum — with altered Aβ42 in the CSF) were followed up for an average of 13 months. We used MultiAtlas, UF2C, and Freesurfer software to evaluate diffusion tensor imaging, FC, and HV, respectively, INNOTEST® kits to measure CSF proteins, and neuropsychological tests. Besides, we performed different MANOVAs with further univariate analyses to differentiate groups. Results During follow-up, 8/30 aMCI-Aβ + converted (26.6%) to AD dementia. There were no differences in multivariate analysis between groups in CSF biomarkers (p = 0.092) or at DMN functional connectivity (p = 0.814). aMCI-Aβ + converters had smaller right HV than controls (p = 0.013), and greater right cingulum parahippocampal bundle radial diffusivity than controls (p < 0.001) and non-converters (p = 0.036). Conclusion In this exploratory study, structural, but not functional, DMN connectivity alterations may differentiate aMCI-Aβ + subjects who converted to AD dementia.